Price
CHART BY
Frequently asked questions
What is Amphastar Pharms's market capitalization?
The market capitalization of Amphastar Pharms is $1.01B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Amphastar Pharms's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Amphastar Pharms is 13.85. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Amphastar Pharms?
Amphastar Pharms's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.706. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Amphastar Pharms's stock?
Currently, 7 analysts cover Amphastar Pharms's stock, with a consensus target price of $22.50. Analyst ratings provide insights into the stock's expected performance.
What is Amphastar Pharms's revenue over the trailing twelve months?
Over the trailing twelve months, Amphastar Pharms reported a revenue of $730.02M.
What is the EBITDA for Amphastar Pharms?
Amphastar Pharms's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $178.99M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Amphastar Pharms?
Amphastar Pharms has a free cash flow of $152.89M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Amphastar Pharms have, and what sector and industry does it belong to?
Amphastar Pharms employs approximately 1,976 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Amphastar Pharms's shares?
The free float of Amphastar Pharms is 30.90M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $1.01B
- EPS (TTM)
- $1.706
- Free Float
- 30.90M
- P/E ratio (TTM)
- 13.85
- Revenue (TTM)
- $730.02M
- EBITDA (TTM)
- $178.99M
- Free Cashflow (TTM)
- $152.89M
Pricing
- 1D span
- $23.49$24.41
- 52W span
- $16.66$29.52
Analyst Ratings
The price target is $22.50 and the stock is covered by 7 analysts.
Buy
0
Hold
6
Sell
1
Information
Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredients. It operates through Pharmaceutical Products segment. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.
- Employees
- 1,976
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- Primary Ticker
- AMPH
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet